| 英文别名 |
Deacetylnorgestimate;(E)- and (Z)-17-deacetyl norgestimate mixture;17-Desacetyl Norgestimate;DEACETYLNORGESTIMATE ((E)- AND (Z)-17-DEACETYL NORGESTIMATE MIXTURE);Norgestimate metabolite Norelgestromin;17-deacetylated norgestimate;17-Deacetylnorgestimate;17-Deacylnorgestimate;18-Methylnorethindrone oxime;BRN 4202099;D-Norgestrel 3-oxime;Levonorgestrel oxime;Norelgestromin;Norplant 3-oxime;RWJ 10553;UNII-R0TAY3X631;Deacetylnorgestimate (Mixture of (E)- And (Z)-17-Deacetyl Norgestimate);Norelgestromin, (E)-;Norelgestromin, (E)-;Norelgestromin, (E)-;anti-Norelgestromin;anti-Norelgestromin;anti-Norelgestromin;(E)-17-Deacetylnorgestimate;(E)-17-Deacetylnorgestimate;(E)-17-Deacetylnorgestimate;AKOS015917579;AKOS015917579;AKOS015917579;D05205;D05205;D05205;BRD-K42504537-001-01-6;BRD-K42504537-001-01-6;BRD-K42504537-001-01-6;(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol;(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol;(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (3E,17a)- (9CI); anti-Norelgestromin;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (3E,17a)- (9CI); anti-Norelgestromin;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (3E,17a)- (9CI); anti-Norelgestromin;1ST10486;1ST10486;1ST10486;NORGESTIMATE IMPURITY C [EP IMPURITY];NORGESTIMATE IMPURITY C [EP IMPURITY];NORGESTIMATE IMPURITY C [EP IMPURITY];18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, OXIME, (3E,17.ALPHA.)-;18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, OXIME, (3E,17.ALPHA.)-;18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, OXIME, (3E,17.ALPHA.)-;Norgestimate impurity C [EP];Norgestimate impurity C [EP];Norgestimate impurity C [EP];DTXCID7026788;DTXCID7026788;DTXCID7026788;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (3E,17alpha)-;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (3E,17alpha)-;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (3E,17alpha)-;SCHEMBL3163347;SCHEMBL3163347;SCHEMBL3163347;(17ALPHA)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-EN-20-YN-3-ONE OXIME;(17ALPHA)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-EN-20-YN-3-ONE OXIME;(17ALPHA)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-EN-20-YN-3-ONE OXIME;BDBM50103633;BDBM50103633;BDBM50103633;Ortho Evra;Ortho Evra;Ortho Evra;Tox21_112647;Tox21_112647;Tox21_112647;17-Deacetyl norgestimate;17-Deacylnorgestimate;17-Deacetyl norgestimate;17-Deacylnorgestimate;17-Deacetyl norgestimate;17-Deacylnorgestimate;Norelgestromin (USP/INN);Norelgestromin (USP/INN);Norelgestromin (USP/INN);NCGC00485891-01;NCGC0... |